Monoamine oxidase inhibitors (MAOI): MAOI extend the consequences of barbiturates probably since metabolism with the barbiturate is inhibited. To handle this latter situation, experiments targeted at correcting brain involvement via direct intraparenchymal or intrathecal vector administration have been carried out with the therapy of mucopolysaccharidose sorts IIIA and IIIB (Tardieu https://bobbyx578rzk4.mdkblog.com/profile